https://stock.noler.com/us/stock/ra-pharmaceuticals-inc https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/accounts-receivable-net https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/conversion-of-stock-amount-converted https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-rent-credit-current https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-deferred-rent https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/defined-contribution-plan-employer-matching-contribution-percent-of-match https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/dividends-common-stock https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/foreign-pretax-income https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/goodwill https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/increase-decrease-in-other-operating-capital-net https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/interest-expense-related-party https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/interest-income-operating https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/lease-cost https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/net-cash-from https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/number-of-reporting-units https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-cost https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-expense https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/other-asset-impairment-charges https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/other-assets https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/other-noncash-expense https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/other-noncash-income-expense https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/paid-in-capital-other https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/paid-in-kind-interest https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/payments-for-proceeds-from-tenant-allowance https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/preferred-stock-redemption-discount https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/pretax-income-domestic https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/reclassification-from-accumulated-oci-current-period-net-of-tax https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/shares-paid-for-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/short-term-lease-cost https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/stock-split-ratio https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/stockholders-equity-change https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/variable-lease-cost https://stock.noler.com/us/stock/ra-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted